Procurement Summary
Country : USA
Summary : Phs 2023-2 Omnibus Solicitation of the Nih and Cdc for Small Business Innovation Research Grant Applications (Parent Sbir [R43/R44] Clinical Trial Required)
Deadline : 05 Apr 2024
Other Information
Notice Type : Tender
TOT Ref.No.: 85625842
Document Ref. No. : PA-23-231
Competition : ICB
Financier : Self Financed
Purchaser Ownership : Public
Tender Value : Refer Document
Purchaser's Detail
Purchaser : NATIONAL INSTITUTES OF HEALTH
NIH Grants Informationgrantsinfo@nih.gov
USA
Email :grantsinfo@nih.gov
Tender Details
Tender are invited for PHS 2023-2 Omnibus Solicitation of the NIH and CDC for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Required)
CFDA Number : 93.361 -- Nursing Research93.394 -- Cancer Detection and Diagnosis Research93.395 -- Cancer Treatment Research93.867 -- Vision Research
Cost Sharing or Matching Requirement : No
Closing Date for Applications: Apr 05, 2024
Posted Date : Jul 12, 2023
Description: This Notice of Funding Opportunity Announcement (NOFO), issued by the National Institutes of Health (NIH) and the Centers for Disease Control and Prevention (CDC) invites eligible United States small businesses to submit Small Business Innovation Research (SBIR) grant applications. United States small businesses that have the research capabilities and technological expertise to contribute to the R and D mission(s) of the NIH and CDC awarding components identified in this NOFO are encouraged to submit SBIR grant applications in response to identified topics (see PHS 2022-2 SBIR/STTR Program Descriptions and Research Topics for NIH, CDC, and FDA).This Parent Funding Opportunity Announcement requires that at least 1 clinical trial be proposed. The proposed project must be related to the programmatic interests of one or more of the participating NIH Institutes and Centers (ICs) based on their scientific missions.
Documents
Tender Notice
PA-23-231-Full-Announcement--PA-23-231.zip